Comparison of intramuscular and subcutaneous administration of marek's disease vaccine
Authors:
Open Access
- 3 January 1986
- journal article
- research article
- Published by Taylor & Francis in Avian Pathology
- Vol. 15 (3) , 569-579
Abstract
Four trials employing 50% protective dose (PD50) assays were performed to compare the efficacy of Marek's disease vaccine after intramuscular (i.m.) and subcutaneous (s.c.) inoculation of specific‐pathogen‐free (SPF) chickens. Female chickens were employed in trials 1 and 2. In trials 3 and 4 the results were separately recorded for both sexes. Cell‐associated Marek's disease virus serotype 1 vaccines derived from strain CVI‐988 were used. Intramuscular administration yielded PD50 estimates which were below the PD50 obtained by the s.c. route in all five pairs of comparable assays. A 4‐fold difference of PD50 estimate, in favour of i.m. inoculation, was observed between the two series of female chickens of the trial which most properly fulfilled the requirements for a PD50 assay. By comparing 25 individual pairs of vaccine dose groups, the best protection was observed in 24 groups of chickens which received the vaccine by i.m. route. These data were statistically analysed by comparing the average degrees of protection provided by i.m. or s.c. inoculation. In trials 1 and 2 the i.m. vaccination provided significantly better protection than the s.c. route. Although not significantly different, the differences in trials 3 and 4 were in the same direction. It is recommended that the potency of the minimally acceptable field dose should be increased if s.c. administration becomes the normal practice.Keywords
This publication has 13 references indexed in Scilit:
- The Prevention of Marek's Disease in Holland by Vaccination with Cell-Associated Vaccines—CV1988 (DUTCH) and FC126 (USA) Results of comparative Field Trials and Routine Vaccinations of Flocks between 1970–1980World's Poultry Science Journal, 1982
- Molecular-biological characterization of Marek's disease virus II. Differentiation of various MDV and HVT strainsVirology, 1982
- Comparative 50% protective dose assays (PD50) of Marke's disease virus strain CVI988Journal of Biological Standardization, 1981
- Differential effect of maternal antibodies on efficacy of cellular and cell‐free Marek's disease vaccinesAvian Pathology, 1979
- Characterization of an Apparently Nononcogenic Marek's Disease Virus23JNCI: Journal of the National Cancer Institute, 1978
- Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assaysAvian Pathology, 1975
- Influence of Age at Exposure on the Pathogenesis of Marek's Disease 2JNCI: Journal of the National Cancer Institute, 1973
- Protection against Marek's Disease by Vaccination with a Herpesvirus of Turkeys1970
- The Attenuation, with Loss of Oncogenicity, of the Herpes-type Virus of Marek's Disease (Strain hprs-16) on Passage in Cell CultureJournal of General Virology, 1969
- Independent-Action and Birth-Death Models in Experimental MicrobiologyMicrobiology and Molecular Biology Reviews, 1965